吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

休市中 12-20 15:59:59 EST

92.57

+1.48

+1.62%

盘后92.56

-0.01-0.01%

19:48 EST

最高93.29	最低90.71	成交量2,253万
今开91.15	昨收91.09	日振幅2.83%
总市值1,154亿	流通市值1,151亿	总股本12.46亿
成交额20.81亿	换手率1.81%	流通股本12.44亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":92.57,"timestamp":1734728399999,"preClose":91.09,"halted":0,"volume":22530186,"hourTrading":{"tag":"盘后","latestPrice":92.56,"preClose":92.57,"latestTime":"19:48 EST","volume":5129084,"amount":474799332.08448,"timestamp":1734742131929},"delay":0,"floatShares":1243802114,"shares":1246265857,"eps":0.097109,"marketStatus":"休市中","marketStatusCode":7,"change":1.48,"latestTime":"12-20 15:59:59 EST","open":91.145,"high":93.29,"low":90.71,"amount":2081108188.997964,"amplitude":0.028324,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.097109,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1734944400000},"adr":0,"listingDate":696056400000,"adjPreClose":91.09,"adrRate":0,"dividendRate":0.033056,"preHourTrading":{"tag":"盘前","latestPrice":91.34,"preClose":91.09,"latestTime":"09:29 EST","volume":8611,"amount":785216.544154,"timestamp":1734704988763},"postHourTrading":{"tag":"盘后","latestPrice":92.56,"preClose":92.57,"latestTime":"19:48 EST","volume":5129084,"amount":474799332.08448,"timestamp":1734742131929},"volumeRatio":3.111475806465498,"impliedVol":0.3476,"impliedVolPercentile":0.9127},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2492785440","title":"吉利德科学上涨1.23%，报92.21美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492785440","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492785440?lang=zh_cn&edition=full","pubTime":"2024-12-20 23:29","pubTimestamp":1734708572,"startTime":"0","endTime":"0","summary":"12月20日，吉利德科学(GILD)盘中上涨1.23%，截至23:29，报92.21美元/股，成交2.65亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。大事提醒：2025年2月11日，吉利德科学将于(美东)盘后披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220233429a1fe43de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220233429a1fe43de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1430594728.SGD","IE00BZ1G4Q59.USD","IE00B3T34201.USD","LU1839511570.USD","IE00B19Z3581.USD","GILD","BK4588","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1066053197.SGD","BK4583","LU2468319806.SGD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4139","IE0002270589.USD","LU0058720904.USD","LU2087621335.USD","BK4550","LU0109394709.USD","BK4566","LU1571399168.USD","IE00BKVL7J92.USD","IE00BSNM7G36.USD","LU1066051498.USD","BK4532","BK4568","BK4585","LU1585245621.USD","LU0889565916.HKD","BK4578"],"gpt_icon":0},{"id":"2492863120","title":"默克公司艾滋病疗法的两项后期研究达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=2492863120","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492863120?lang=zh_cn&edition=full","pubTime":"2024-12-19 21:12","pubTimestamp":1734613933,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["LU1839511570.USD","IE00B3T34201.USD","LU0889565916.HKD","MRK","SG9999015341.SGD","BK4585","LU1066051498.USD","LU0965509101.SGD","LU1116320737.USD","LU2361045086.USD","IE00B1BXHZ80.USD","SG9999001440.SGD","BK4559","LU2023250504.SGD","LU1941712348.USD","SG9999001176.SGD","LU0211331839.USD","LU0058720904.USD","LU0109394709.USD","LU0265550946.USD","LU0208291251.USD","LU1430594728.SGD","LU1974910355.USD","SG9999002232.USD","SG9999014559.SGD","IE00BLSP4452.SGD","GILD","LU1989772840.SGD","LU1037948541.HKD","BK4583","LU0203345920.USD","BK4533","LU1066053197.SGD","LU0006306889.USD","LU0238689110.USD","LU0122379950.USD","LU0965509283.SGD","IE0002270589.USD","LU2361044949.HKD","LU0265550359.USD","LU1061106388.HKD","LU1934455194.USD","LU1116320901.HKD","IE00BKVL7J92.USD","LU0266013472.USD","LU2468319806.SGD","LU1066051225.USD","IE00B19Z3581.USD","BK4534","SGXZ57979304.SGD"],"gpt_icon":0},{"id":"2492308130","title":"吉利德科学下跌1.21%，报91.68美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492308130","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492308130?lang=zh_cn&edition=full","pubTime":"2024-12-19 03:03","pubTimestamp":1734548630,"startTime":"0","endTime":"0","summary":"12月19日，吉利德科学(GILD)盘中下跌1.21%，截至03:03，报91.68美元/股，成交1.88亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。大事提醒：2025年2月11日，吉利德科学将于(美东)盘后披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/19030346565839.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["LU0289739699.SGD","LU1430594728.SGD","BK4139","BK4550","LU1585245621.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","LU1839511570.USD","IE0002270589.USD","LU1571399168.USD","BK4532","BK4566","IE00B19Z3581.USD","IE00B7SZLL34.SGD","BK4578","IE00BZ1G4Q59.USD","LU0234570918.USD","IE00BKVL7J92.USD","LU2468319806.SGD","GILD","LU2087621335.USD","BK4568","BK4588","IE00BSNM7G36.USD","BK4583","LU0889565916.HKD","LU0109394709.USD","LU0320765992.SGD","LU0058720904.USD","BK4585","LU1066051498.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2492971984","title":"重磅！百亿美元豪赌！吉利德想靠CAR-T再赢一次！","url":"https://stock-news.laohu8.com/highlight/detail?id=2492971984","media":"谈思生物","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492971984?lang=zh_cn&edition=full","pubTime":"2024-12-18 16:23","pubTimestamp":1734510221,"startTime":"0","endTime":"0","summary":"而目前，相比这些更早期的投资，吉利德显然更希望依靠CAR-T疗法再次取得成功。/ 01 /CD19 CAR-T的下坡路2017年，吉利德公司斥资119亿美元收购Kite，这一行动标志着其向肿瘤治疗领域的战略性转型。通过这次收购，吉利德获得了全球仅有的两款获批的CAR-T疗法之一——Yescarta，从而迅速跻身全球细胞与基因治疗领域的领军企业。然而，目前在美国，获批上市的CD19 CAR-T疗法已达5款，在激烈的市场竞争中，吉利德的CAR-T疗法似乎开始面临销售挑战。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218162530a1f80504&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241218162530a1f80504&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4550","LU0234570918.USD","IE00B19Z3B42.SGD","BK4139","LU0058720904.USD","IE00BSNM7G36.USD","IE0002270589.USD","BK4585","BK4578","LU1571399168.USD","GILD","LU1839511570.USD","LU2087621335.USD","LU0889565916.HKD","LU0320765992.SGD","IE00B7SZLL34.SGD","LU0109394709.USD","LU1430594728.SGD","BK4532","IE00B3T34201.USD","BK4568","CAR","IE00BKVL7J92.USD","LU1585245621.USD","BK4022","IE00B19Z3581.USD","LU1066053197.SGD","BK4230","BK4566","IE00BZ1G4Q59.USD","LU2468319806.SGD","LU0289739699.SGD","BK4583","LU1066051498.USD","BK4588"],"gpt_icon":0},{"id":"2492950157","title":"卫生官员表示，到 2025 年，新型艾滋病预防药物将进入最贫困国家","url":"https://stock-news.laohu8.com/highlight/detail?id=2492950157","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492950157?lang=zh_cn&edition=full","pubTime":"2024-12-17 22:00","pubTimestamp":1734444013,"startTime":"0","endTime":"0","summary":"路透伦敦12月17日 - 一位全球卫生官员周二告诉路透记者，一种新型长效艾滋病预防药物将于2025年底或2026年初到达世界上最贫穷的国家。今年的临床试验显示， ，它在预防感染方面也非常有效，吉利德公司正在寻求在全球范围内批准它的新用途。吉利德公司今年10月与六家仿制药生产商签署了 ，以便在120个中低收入国家以更低的价格生产和销售来那卡韦。吉利德科学公司没有立即回应置评请求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241217:nL4T3NI0YV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1571399168.USD","BK4583","BK4139","IE00BSNM7G36.USD","BK4578","LU0234570918.USD","BK4566","LU0109394709.USD","LU2468319806.SGD","GILD","LU1066053197.SGD","IE0002270589.USD","LU2087621335.USD","IE00B7SZLL34.SGD","BK4550","IE00B19Z3B42.SGD","LU1066051498.USD","LU1430594728.SGD","LU0289739699.SGD","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0320765992.SGD","LU1839511570.USD","LU0889565916.HKD","LU1585245621.USD","BK4588","LU0058720904.USD","IE00B19Z3581.USD","BK4532","BK4568","BK4585"],"gpt_icon":0},{"id":"2491932106","title":"金十数据整理：每日美股市场要闻速递（12月16日 周一）","url":"https://stock-news.laohu8.com/highlight/detail?id=2491932106","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491932106?lang=zh_cn&edition=full","pubTime":"2024-12-16 21:05","pubTimestamp":1734354358,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["VWAGY","LU2430703251.USD","LU2461242641.AUD","BK4575","LU0234572021.USD","LU1989771016.USD","LU0114720955.EUR","IE0009355771.USD","SNY","LU1868836591.USD","03160","BK4532","IE00B3S45H60.SGD","LU0011850046.USD","LU2237443978.SGD","VLKAY","IE00BJJMRY28.SGD","LU0494093205.USD","LU0077335932.USD","LU1585245621.USD","LU2237443895.HKD","MACW.SI","LU1974910355.USD","LU2023250843.SGD","LU0784383803.USD","LU1823568750.SGD","LU0314106906.USD","LU0256863902.USD","HK0000306685.HKD","LU1778281490.HKD","SG9999014542.SGD","GILD","SHEL","IE0004086264.USD","IE0002141913.USD","LU0965509010.AUD","SFTBY","RDSA.UK","01801","LU0949170426.SGD","RDS.A","RDS.B","AAPL","LLY","0O59.UK","LU1791710400.SGD","LU1116320901.HKD","NVO","LU0385154629.USD","IE00B19Z8X17.USD"],"gpt_icon":0},{"id":"2491166079","title":"赛诺菲(SNY.US)前全球开发负责人加入吉利德(GILD.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=2491166079","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491166079?lang=zh_cn&edition=full","pubTime":"2024-12-16 20:32","pubTimestamp":1734352352,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，近日，吉利德宣布Dietmar Berger博士将于2025年1月2日加入公司，接替Merdad Parsey博士担任首席医学官，并将成为吉利德高级领导团队的一员。他将负责吉利德领先的病毒学、肿瘤学和炎症管线产品，并将监督吉利德的全球开发和医学事务部门。在加入吉利德之前，Dietmar Berger博士在赛诺菲担任CMO兼全球开发负责人，负责领导赛诺菲重点治疗领域的药物开发科学、战略和运营。在加入赛诺菲之前，Dietmar Berger博士曾在Atara、基因泰克、拜耳和安进等多家公司任职。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1225628.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4139","BK4568","IE00B19Z3581.USD","IE00BFXG1179.USD","LU2468319806.SGD","LU1066053197.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4550","BK4007","LU0058720904.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0234570918.USD","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","LU2087621335.USD","LU1839511570.USD","IE00B7SZLL34.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4588","GILD","SNY","BK4585","LU0320765992.SGD","BK4583","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1066051498.USD","BK4578","IE00B19Z3B42.SGD","BK4566","BK4532"],"gpt_icon":0},{"id":"2491634712","title":"吉利德：想靠CAR-T再赢一次","url":"https://stock-news.laohu8.com/highlight/detail?id=2491634712","media":"钛媒体","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491634712?lang=zh_cn&edition=full","pubTime":"2024-12-16 13:59","pubTimestamp":1734328740,"startTime":"0","endTime":"0","summary":"而眼下，相比这些更早期的赌注，吉利德显然更希望靠CAR-T再赢一次。主打安全性亮点的anito-cel，被吉利德寄予厚望，其认为这将是一款BIC产品；加上Kite已经具备的大规模生产能力及CAR-T商业化网络，其认为anito-cel有能力角逐CAR-T这一近千亿市场。CD19 CAR-T的下坡路2017年斥资119亿美元收购Kite，是吉利德转向肿瘤领域的关键举措，这让其获得了全球唯二获批上市的CAR-T疗法Yescarta，更是一跃成为全球细胞与基因治疗的领头羊。可以说，吉利德在CAR-T赛道，风光无两。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216140013ab7b7fe8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216140013ab7b7fe8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","GILD","BK4583","IE00B19Z3581.USD","LU0058720904.USD","CAR","LU1839511570.USD","BK4022","IE00BZ1G4Q59.USD","LU1066053197.SGD","LU1430594728.SGD","LU1571399168.USD","IE00BSNM7G36.USD","BK4566","LU2087621335.USD","BK4588","BK4550","LU1066051498.USD","IE00B3T34201.USD","LU2468319806.SGD","LU0109394709.USD","IE0002270589.USD","BK4568","BK4578","BK4532","LU0234570918.USD","LU0320765992.SGD","LU1585245621.USD","IE00B19Z3B42.SGD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","BK4230","LU0289739699.SGD","BK4585","LU0889565916.HKD"],"gpt_icon":0},{"id":"2491637512","title":"吉利德科学下跌1.3%，报90.415美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491637512","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491637512?lang=zh_cn&edition=full","pubTime":"2024-12-13 22:36","pubTimestamp":1734100577,"startTime":"0","endTime":"0","summary":"12月13日，吉利德科学(GILD)盘中下跌1.3%，截至22:36，报90.415美元/股，成交1845.18万美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。大事提醒：12月11日，吉利德科学获加拿大皇家银行重申评级Sector Perform，目标价84美元。2025年2月4日，吉利德科学将披露2024财年年报（数据来源于纳斯达克官网，预计披露日期为美国当地时间，实际披露日期以公司公告为准）。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/13223646380397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4139","BK4568","IE00B19Z3581.USD","LU2468319806.SGD","LU1066053197.SGD","LU0889565916.HKD","LU1430594728.SGD","BK4550","LU0058720904.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0234570918.USD","LU0289739699.SGD","LU1571399168.USD","LU1585245621.USD","LU2087621335.USD","LU1839511570.USD","IE00B7SZLL34.SGD","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4588","GILD","BK4585","LU0320765992.SGD","BK4583","IE00BSNM7G36.USD","IE00B3T34201.USD","LU1066051498.USD","BK4578","IE00B19Z3B42.SGD","BK4566","BK4532"],"gpt_icon":0},{"id":"2491416363","title":"吉利德任命赛诺菲官员 Dietmar Berger 为下一任首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=2491416363","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491416363?lang=zh_cn&edition=full","pubTime":"2024-12-13 06:47","pubTimestamp":1734043657,"startTime":"0","endTime":"0","summary":"吉利德任命赛诺菲官员 Dietmar Berger 为下一任首席医疗官路透12月12日 - 吉利德科学公司GILD.O周四表示，已任命赛诺菲公司的迪特玛-伯杰为公司首席医疗官，接替准备明年初离职的现任首席医疗官梅尔达德-帕西。伯杰将于1月2日加入，他是法国制药巨头赛诺菲SASY.PA的现任首席医疗官。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4S3ND1P5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD"],"gpt_icon":0},{"id":"2490889313","title":"2023 年，无依据的价格上涨将使美国药品支出增加 8.15 亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490889313","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490889313?lang=zh_cn&edition=full","pubTime":"2024-12-12 21:00","pubTimestamp":1734008415,"startTime":"0","endTime":"0","summary":"2023 年，无依据的价格上涨将使美国药品支出增加 8.15 亿美元Sriparna  Roy路透12月12日 - 一个有影响力的药品定价监督机构周四表示，2023 年对美国医疗支出增长贡献最大的 10 种药品中，有 5 种药品的提价没有得到临床证据的支持，导致成本增加了 8.15 亿美元。报告称，该疗法的上市价格上涨了7.6%，使美国的支出增加了约1.9亿美元。根据美国定价研究公司的数据，去年，10 种高支出药品中有 8 种大幅提价，增加了 12.7 亿美元的成本。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241212:nL4S3ND0XB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF631.EUR","BK4550","LU0640476718.USD","LU0965509101.SGD","GILD","EXEL","LU1291159041.SGD","LU1061106388.HKD","SG9999014575.USD","BK4588","LU1934455863.HKD","IE00BSNM7G36.USD","LU2023250504.SGD","BK4533","LU0106261372.USD","LU2602419157.SGD","IE00BVYPNV92.GBP","LU1934455277.USD","LU0170899867.USD","SG9999013999.USD","LU0912757837.SGD","LU0965508806.USD","LU1032466523.USD","MRK","BK4516","LU0456855351.SGD","SG9999015341.SGD","LU0889566641.SGD","LU0882574055.USD","LU1196500208.SGD","LU1732800096.USD","LU2087621335.USD","LU2089984988.USD","LU0320765489.SGD","LU1037948541.HKD","PFE","LU1057294990.SGD","LU0070302665.USD","SG9999001176.USD","SG9999014542.SGD","LU1941712264.USD","LU1221951046.USD","LU1941712348.USD","LU0965509283.SGD","JNJ","SG9999002224.SGD","LU1066051498.USD","LU1778281490.HKD","LU0238689110.USD","BK4592"],"gpt_icon":1},{"id":"2490083532","title":"奥本海默上调吉利德科学目标价至115美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2490083532","media":"新浪财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490083532?lang=zh_cn&edition=full","pubTime":"2024-12-11 17:05","pubTimestamp":1733907933,"startTime":"0","endTime":"0","summary":"格隆汇12月11日｜奥本海默：将吉利德科学的目标价从105美元上调至115美元，维持“跑赢大市”评级。(格隆汇)\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：郭明煜","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2024-12-11/doc-inczarzp3944646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["GILD"],"gpt_icon":0},{"id":"2490075433","title":"吉利德迷航在抗肿瘤红海中","url":"https://stock-news.laohu8.com/highlight/detail?id=2490075433","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490075433?lang=zh_cn&edition=full","pubTime":"2024-12-11 07:28","pubTimestamp":1733873280,"startTime":"0","endTime":"0","summary":"恰恰也正是因为激进的并购策略，导致吉利德连续大手笔并购抗癌企业，但收效甚微，渐渐在肿瘤赛道迷失。正是基于这一突破性的研究，吉利德在2001年推出了自己的第一款抗HIV药物Viread，并很快成为爆款药物。凭借这些药物组合，吉利德成功在2013年将产品营收额提升至108亿美元，跻身世界一流制药企业梯队。2023年，吉利德全年产品销售收入269亿美元，其中艾滋病治疗药物的销售额达到182亿美元，占比达到67.7%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211074744ab6de15f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211074744ab6de15f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B7SZLL34.SGD","BK4583","LU1571399168.USD","BK4550","BK4568","BK4566","LU0058720904.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2087621335.USD","LU0320765992.SGD","BK4588","LU1585245621.USD","BK4139","BK4578","LU1839511570.USD","LU2468319806.SGD","IE0002270589.USD","LU0289739699.SGD","IE00B3T34201.USD","IE00BZ1G4Q59.USD","LU1430594728.SGD","GILD","BK4585","LU0889565916.HKD","LU0234570918.USD","IE00B19Z3581.USD","BK4532","IE00BKVL7J92.USD","LU0109394709.USD","LU1066053197.SGD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2490031797","title":"吉利德科学下跌1.25%，报90.98美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2490031797","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490031797?lang=zh_cn&edition=full","pubTime":"2024-12-10 01:23","pubTimestamp":1733765022,"startTime":"0","endTime":"0","summary":"12月10日，吉利德科学(GILD)盘中下跌1.25%，截至01:23，报90.98美元/股，成交1.53亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/10012346192771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["IE00B3T34201.USD","GILD","LU0058720904.USD","LU2087621335.USD","BK4585","IE00B7SZLL34.SGD","LU1585245621.USD","BK4532","BK4578","IE00BSNM7G36.USD","LU0109394709.USD","IE00B19Z3581.USD","BK4568","LU1839511570.USD","BK4588","IE00BKVL7J92.USD","BK4583","IE0002270589.USD","LU1430594728.SGD","LU1066053197.SGD","BK4566","IE00B19Z3B42.SGD","LU0289739699.SGD","LU1066051498.USD","LU0234570918.USD","LU2468319806.SGD","IE00BZ1G4Q59.USD","LU0889565916.HKD","LU1571399168.USD","BK4550","LU0320765992.SGD","BK4139"],"gpt_icon":0},{"id":"2490252767","title":"BUZZ-血癌细胞疗法试验数据良好，Arcellx公司业绩攀升","url":"https://stock-news.laohu8.com/highlight/detail?id=2490252767","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490252767?lang=zh_cn&edition=full","pubTime":"2024-12-09 20:02","pubTimestamp":1733745748,"startTime":"0","endTime":"0","summary":"    12月9日 - ** 细胞疗法开发商Arcellx  的股价盘前上涨8%至91.35美元** 该公司称其细胞疗法anito-cel在一项测试多发性骨髓瘤患者的中期试验中显示出97%的总体反应率  ** 总体反应率是指对疗法有部分或完全反应的患者比例。** 券商 TD Cowen 称，anito-cel 的疗效至少与 Carvykti 相当，但安全性更高 ** ACLX 的疗法没有显示出对神经系统的延迟损伤，但在试验期间有 3 人因不良事件死亡** 截至上次收盘，股价累计上涨 52.3","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BVYPNV92.GBP","JNJ","ACLX","LU0792757196.USD","SG9999001440.SGD","LU1221951046.USD","IE00B1BXHZ80.USD","LU1032466523.USD","LU1914381329.SGD","BK4533","LU1162221912.USD","LU1585245621.USD","LU1718418525.SGD","LU0795875086.SGD","LU1261432733.SGD","IE00B19Z3B42.SGD","IE00BVYPNW00.USD","LU1066053197.SGD","LU1506573853.SGD","LU1571399168.USD","BK4532","LU0345769128.USD","LU1244550577.SGD","BK4534","LU0466842654.USD","LU1732800096.USD","IE00B7SZLL34.SGD","LU0234570918.USD","BK4559","GILD","IE00BFTCPJ56.SGD","IE0002141913.USD","LU0912757837.SGD","LU2087621335.USD","LU1196500208.SGD","LU2602419157.SGD","BK4588","BK4583","LU1032955483.USD","IE00BGHQF631.EUR","LU0203345920.USD","BK4504","IE000M9KFDE8.USD","IE0009355771.USD","LU1674673691.USD","LU0058720904.USD","SG9999002224.SGD","LU1267930813.SGD","LU0203347892.USD","LU0889566641.SGD"],"gpt_icon":0},{"id":"2489335254","title":"吉利德科学下跌1.23%，报92.245美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2489335254","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489335254?lang=zh_cn&edition=full","pubTime":"2024-12-07 01:38","pubTimestamp":1733506690,"startTime":"0","endTime":"0","summary":"12月7日，吉利德科学(GILD)盘中下跌1.23%，截至01:38，报92.245美元/股，成交1.31亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/07013846126300.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4578","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4566","BK4532","GILD","LU1571399168.USD","LU0889565916.HKD","LU0289739699.SGD","IE00B3T34201.USD","LU0058720904.USD","BK4588","BK4550","LU0109394709.USD","LU1066051498.USD","LU1839511570.USD","IE00B7SZLL34.SGD","BK4585","LU1430594728.SGD","LU2087621335.USD","LU1066053197.SGD","IE00B19Z3581.USD","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","BK4139","LU2468319806.SGD","IE00BSNM7G36.USD","LU0320765992.SGD","LU1585245621.USD","LU0234570918.USD","BK4583","BK4568"],"gpt_icon":0},{"id":"2488196849","title":"金十数据整理：每日美股市场要闻速递（12月4日 周三）","url":"https://stock-news.laohu8.com/highlight/detail?id=2488196849","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488196849?lang=zh_cn&edition=full","pubTime":"2024-12-04 21:35","pubTimestamp":1733319335,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["FTC","IE00BN8TJ469.HKD","LU0061474705.USD","LU0289961442.SGD","159582","NUGT","GILD","RIO.UK","LU2041044095.USD","SGCmain","GOOGL","GDX","RIO","SImain","GLD","IAU","ADC","IE00B775SV38.USD","LLY","NXPI","ES3.SI","161631","AAPL","GCmain","NVO","LU2106854487.HKD","LU2764263039.SGD","GOOG","STLA","MRK","S68.SI","LU0795875169.SGD","STI.SI","MGCmain","SG9999014914.USD","SGUmain","LU1582987597.SGD","LU1280957306.USD","LU1934455863.HKD","CRM","159934","518880","SG9999013999.USD","FSTM.SI","LU2065171402.SGD","FSTAS.SI","LU1917777945.USD","DUST","MSFT"],"gpt_icon":0},{"id":"2488159651","title":"特朗普研发政策引爆现金流！这些公司迎来“财务春天”！","url":"https://stock-news.laohu8.com/highlight/detail?id=2488159651","media":"金十数据","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488159651?lang=zh_cn&edition=full","pubTime":"2024-12-04 18:44","pubTimestamp":1733309086,"startTime":"0","endTime":"0","summary":"特朗普的研发新政可能为美国企业带来一场“现金流革命”！通过允许公司即时记录研发支出，企业不仅能减少税负，还能大幅提升资金流动。","market":"hk","thumbnail":"https://static.tigerbbs.com/ce3169183f95efe0c5e26aef37b958ea","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/ce3169183f95efe0c5e26aef37b958ea"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","isJumpTheme":false,"source_url":"https://xnews.jin10.com/webapp/details.html?id=155116&type=news&data_type=0","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"xnew_highlight","symbols":["GILD","BK4524","LU1814569148.SGD","LU2756315664.SGD","IE00B19Z9505.USD","BK4227","BK4566","LU2403377893.USD","LU0265550946.USD","LU1074936037.SGD","LU1366192091.USD","LU1242518857.USD","LU2054465674.USD","MRK","SG9999013999.USD","LU1066051225.USD","SGXZ99366536.SGD","BK4550","ZM","IE0004445015.USD","LU1839511570.USD","LU0795875169.SGD","SG9999015945.SGD","LU2112291526.USD","LU1670711123.USD","LU2213496289.HKD","LU1430594728.SGD","LU2360106780.USD","LU2133065610.SGD","LU0058720904.USD","LU2065171402.SGD","LU0882574139.USD","META","LU1057294990.SGD","LYFT","LU0912757837.SGD","LU1116320901.HKD","IE000M9KFDE8.USD","IE00B19Z8W00.USD","LU0106261372.USD","IE00BK4W5M84.HKD","BIIB","IE00BMPRXQ63.HKD","LU0097036916.USD","IE00BKDWB100.SGD","SG9999014567.USD","PYPL","EA","LU0079474960.USD","BK4085"],"gpt_icon":1},{"id":"2488315884","title":"吉利德(GILD.US)与Tubulis达成合作 共同开发针对实体瘤靶点的抗体偶联药物","url":"https://stock-news.laohu8.com/highlight/detail?id=2488315884","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488315884?lang=zh_cn&edition=full","pubTime":"2024-12-04 15:36","pubTimestamp":1733297786,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，吉利德科学与Tubulis今日宣布，双方已签署一项独家选择权和许可协议，旨在共同发现并开发针对实体瘤靶点的抗体偶联药物。根据协议，吉利德将获得Tubulis专有技术平台Tubutecan和Alco5的使用权。协议条款规定，Tubulis将获得2000万美元的预付款;若吉利德行使选择权，则需支付额外3000万美元的选择权费用。此外，Tubulis还可获得最高达4.15亿美元的开发与商业化里程碑等款项。Tubulis将负责ADC项目的早期研究和开发工作。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1220175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2468319806.SGD","BK4568","LU2087621335.USD","BK4532","BK4139","IE0002270589.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","LU1585245621.USD","BK4550","IE00B19Z3581.USD","LU0234570918.USD","BK4566","BK4578","LU1066051498.USD","LU0109394709.USD","LU0320765992.SGD","LU0889565916.HKD","LU0058720904.USD","IE00B7SZLL34.SGD","LU0289739699.SGD","LU1430594728.SGD","LU1571399168.USD","LU1839511570.USD","IE00BKVL7J92.USD","GILD","BK4583","IE00BSNM7G36.USD","LU1066053197.SGD","BK4585","IE00B3T34201.USD","BK4588"],"gpt_icon":0},{"id":"2488975018","title":"吉利德科学下跌1.23%，报92.859美元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2488975018","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488975018?lang=zh_cn&edition=full","pubTime":"2024-12-04 04:52","pubTimestamp":1733259153,"startTime":"0","endTime":"0","summary":"12月4日，吉利德科学(GILD)盘中下跌1.23%，截至04:52，报92.859美元/股，成交2.98亿美元。财务数据显示，截至2024年09月30日，吉利德科学收入总额211.85亿美元，同比增长5.91%；归母净利润-13.03亿美元，同比减少130.76%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2024/12/04045245980943.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4568","GILD","IE00B3T34201.USD","IE00B19Z3B42.SGD","LU2468319806.SGD","IE00B19Z3581.USD","LU0289739699.SGD","BK4588","LU0320765992.SGD","LU1066051498.USD","BK4578","IE00BSNM7G36.USD","BK4583","BK4139","LU1066053197.SGD","BK4566","BK4532","LU1571399168.USD","LU1585245621.USD","LU0109394709.USD","LU0889565916.HKD","LU1430594728.SGD","BK4550","LU1839511570.USD","BK4585","LU0234570918.USD","LU2087621335.USD","IE00BKVL7J92.USD","IE0002270589.USD","IE00B7SZLL34.SGD","IE00BZ1G4Q59.USD","LU0058720904.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":0.0078},{"period":"1month","weight":0.0445},{"period":"3month","weight":0.1028},{"period":"6month","weight":0.3099},{"period":"1year","weight":0.1728},{"period":"ytd","weight":0.1427}],"compareEarnings":[{"period":"1week","weight":-0.0221},{"period":"1month","weight":0.0006},{"period":"3month","weight":0.0397},{"period":"6month","weight":0.0851},{"period":"1year","weight":0.2499},{"period":"ytd","weight":0.243}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.5625,"avgChangeRate":0.041198},{"month":2,"riseRate":0.393939,"avgChangeRate":0.002047},{"month":3,"riseRate":0.545455,"avgChangeRate":-0.009403},{"month":4,"riseRate":0.545455,"avgChangeRate":0.013826},{"month":5,"riseRate":0.545455,"avgChangeRate":0.020012},{"month":6,"riseRate":0.636364,"avgChangeRate":0.026233},{"month":7,"riseRate":0.545455,"avgChangeRate":0.01619},{"month":8,"riseRate":0.545455,"avgChangeRate":0.033979},{"month":9,"riseRate":0.575758,"avgChangeRate":0.032629},{"month":10,"riseRate":0.515152,"avgChangeRate":0.000869},{"month":11,"riseRate":0.636364,"avgChangeRate":0.039409},{"month":12,"riseRate":0.393939,"avgChangeRate":0.011233}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}